Global prescription dermatology therapeutics market expected to generate around USD 53.9 billion by 2024, at a CAGR of around 9.9% between 2018 and 2024. Skin is vulnerable to a wide variety of toxins and microbes as it is the largest and most exposed organ. Prolonged exposure of skin to toxins results in various kinds of skin disorders.
Prescription Dermatology Therapeutics Market
The report covers a forecast and an analysis of the prescription dermatology therapeutics market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the prescription dermatology therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the prescription dermatology therapeutics market on a global and regional level.
In order to give the users of this report a comprehensive view of the prescription dermatology therapeutics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product type launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the prescription dermatology therapeutics market on a global and regional basis.
The study provides a decisive view of the prescription dermatology therapeutics market by segmenting the market based on product type, distribution channel, and region. The segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. By product type, the prescription dermatology therapeutics market includes psoriasis drugs, acne and rosacea drugs, dermatitis and seborrhea drugs, skin cancer, and fungal infection drugs. The distribution channel segment includes mail order pharmacies, retail pharmacies, and hospital pharmacies.
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries, such as the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.
The report also includes detailed profiles of various end players, such as Novartis AG, AbbVie, Inc., Amgen, Inc., Janssen Biotech, Inc., Celgene Corporation, Eli Lilly and Company, Pfizer, Inc., Bausch Health Companies, Inc., LEO Pharma A/S, Aurobindo Pharma Ltd., Sun Pharmaceuticals Ltd., and Aclaris Therapeutics, Inc., among others.
This report segments the global prescription dermatology therapeutics market into:
Global Prescription Dermatology Therapeutics Market: By Product Type
Global Prescription Dermatology Therapeutics Market: By Distribution Channel
Global Prescription Dermatology Therapeutics Market: By Region